317 related articles for article (PubMed ID: 32752030)
1. Roles Played by Biomarkers of Kidney Injury in Patients with Upper Urinary Tract Obstruction.
Washino S; Hosohata K; Miyagawa T
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752030
[TBL] [Abstract][Full Text] [Related]
2. Emerging urinary markers of renal injury in obstructive nephropathy.
Lucarelli G; Mancini V; Galleggiante V; Rutigliano M; Vavallo A; Battaglia M; Ditonno P
Biomed Res Int; 2014; 2014():303298. PubMed ID: 25101270
[TBL] [Abstract][Full Text] [Related]
3. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
[TBL] [Abstract][Full Text] [Related]
4. KIM-1 Is a Potential Urinary Biomarker of Obstruction: Results from a Prospective Cohort Study.
Olvera-Posada D; Dayarathna T; Dion M; Alenezi H; Sener A; Denstedt JD; Pautler SE; Razvi H
J Endourol; 2017 Feb; 31(2):111-118. PubMed ID: 27852120
[TBL] [Abstract][Full Text] [Related]
5. The Use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic and Prognostic Biomarker in Urinary Tract Obstruction: a Systematic Review.
Brewin A; Sriprasad S; Somani B
Curr Urol Rep; 2022 Aug; 23(8):155-163. PubMed ID: 35678987
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
[TBL] [Abstract][Full Text] [Related]
7. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
8. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
George B; Joy MS; Aleksunes LM
Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
[TBL] [Abstract][Full Text] [Related]
9. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
Waring WS; Moonie A
Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
[TBL] [Abstract][Full Text] [Related]
10. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
Hosohata K; Ando H; Fujimura A
J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
12. Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.
Urbschat A; Gauer S; Paulus P; Reissig M; Weipert C; Ramos-Lopez E; Hofmann R; Hadji P; Geiger H; Obermüller N
Eur J Clin Invest; 2014 Jul; 44(7):652-9. PubMed ID: 24837251
[TBL] [Abstract][Full Text] [Related]
13. A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study.
Washino S; Hosohata K; Oshima M; Okochi T; Konishi T; Nakamura Y; Saito K; Miyagawa T
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791405
[No Abstract] [Full Text] [Related]
14. Urinary biomarkers in hydronephrosis.
Madsen MG
Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
[TBL] [Abstract][Full Text] [Related]
15. Novel acute kidney injury biomarkers: their characteristics, utility and concerns.
Beker BM; Corleto MG; Fieiras C; Musso CG
Int Urol Nephrol; 2018 Apr; 50(4):705-713. PubMed ID: 29307055
[TBL] [Abstract][Full Text] [Related]
16. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
18. Tubulointerstitial Biomarkers for Diabetic Nephropathy.
Satirapoj B
J Diabetes Res; 2018; 2018():2852398. PubMed ID: 29577044
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of kidney injury.
Urbschat A; Obermüller N; Haferkamp A
Biomarkers; 2011 Jul; 16 Suppl 1():S22-30. PubMed ID: 21707441
[TBL] [Abstract][Full Text] [Related]
20. Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study.
Legrand M; De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Sambhare R; Di Somma S; Mebazaa A; Vaidya VS; Januzzi JL;
PLoS One; 2014; 9(11):e112313. PubMed ID: 25386851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
